Changes in the TME with antitumor effects can also be made by targeting angiogenic processes in NB, since angiogenesis and the overexpression of proangiogenic factors like VEGF are correlated with high-risk NB [111]. The gene discussed is VEGFA; the disease is neuroblastoma.